Skip to main content
    B

    Barinthus Biotherapeutics plc (BRNS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • PINK

    $0.74
    +0.00 (+0.00%)

    Market Cap: $30.23M

    Last updated: Nov 13, 2026 at 4:00 PM ET

    Barinthus Biotherapeutics plc (BRNS) Earnings: Report Dates and Results

    Updated Aug 6, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Barinthus Biotherapeutics (BRNS) is expected to report earnings on Mar 11, 2027. In the quarter ended Jun 30, 2026, Barinthus Biotherapeutics reported EPS of -$0.26, above the -$0.28 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    73%(16/22)
    Avg Surprise
    +32.79%
    Streak
    4 Q

    Upcoming Estimates

    Results pendingPeriod ending Sep 30, 2026
    EPS Consensus-$0.26
    Range-$0.27 - -$0.25
    2 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.29+10.3%
    60d ago-$0.29+10.3%
    30d ago-$0.29+10.3%
    7d ago-$0.25-4.0%
    Current-$0.26
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts
    Reports Mar 11, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.27
    RangeN/A
    4 analysts
    Revenue Consensus
    N/A
    RangeN/A

    Next Report

    BRNS has an expected report date of Mar 11, 2027.

    Earnings History

    Of the 22 quarters below that had an estimate, BRNS beat 16 and missed 6. The widest gap in the table came in the quarter ended Jun 30, 2022, when EPS landed 207.50% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Jun 30, 2026-$0.26-$0.28-$0.28 - -$0.28+7.14%BeatN/A10 up, 1 downAug 6, 2026N/A
    Mar 31, 2026-$0.14-$0.28-$0.28 - -$0.28+50.00%BeatN/A10 up, 1 downApr 30, 2026N/A
    Dec 31, 2025-$0.27-$0.39-$0.40 - -$0.29+29.82%BeatN/A21 up, 0 downMar 13, 2026N/A
    Sep 30, 2025-$0.24-$0.39-$0.45 - -$0.34+38.46%BeatN/A20 up, 0 downNov 7, 2025N/A
    Jun 30, 2025-$0.52-$0.29-$0.37 - -$0.29-79.31%MissN/A21 up, 1 downAug 7, 2025N/A
    Mar 31, 2025-$0.49-$0.36-$0.41 - -$0.30-36.11%MissN/A31 up, 1 downMay 7, 2025N/A
    Dec 31, 2024-$0.20-$0.37-$0.42 - -$0.29+45.38%BeatN/A31 up, 0 downMar 20, 2025N/A
    Sep 30, 2024-$0.21-$0.44-$0.49 - -$0.41+52.27%BeatN/A30 up, 0 downNov 6, 2024$14.97M
    Jun 30, 2024-$0.43-$0.41-$0.46 - -$0.38-4.88%MissN/A30 up, 0 downAug 8, 2024N/A
    Mar 31, 2024-$0.40-$0.61-$0.67 - -$0.35+34.43%BeatN/A40 up, 0 downMay 13, 2024N/A
    Dec 31, 2023-$0.45-$0.50-$0.62 - -$0.27+10.00%BeatN/A50 up, 0 downMar 20, 2024$5.37M
    Sep 30, 2023-$0.37-$0.55-$0.55 - -$0.50+32.73%Beat-268.2%30 up, 0 downNov 9, 2023N/A
    Jun 30, 2023-$0.62-$0.59-$0.69 - -$0.46-5.08%Miss-244.2%30 up, 0 downAug 10, 2023$334000
    Mar 31, 2023-$0.48-$0.58-$0.68 - -$0.35+17.24%Beat-785.7%30 up, 0 downMay 12, 2023$468000
    Dec 31, 2022-$0.57-$0.42-$0.43 - -$0.42-35.71%MissN/A20 up, 0 downMar 30, 2023$6.46M
    Sep 30, 2022$0.22-$0.52N/A+142.31%BeatN/A30 up, 0 downNov 10, 2022$6.17M
    Jun 30, 2022$0.43-$0.40N/A+207.50%BeatN/AN/A1 up, 0 downAug 9, 2022$17.06M
    Mar 31, 2022$0.07-$0.31-$0.43 - -$0.26+122.58%BeatN/A40 up, 0 downJun 29, 2022$15.02M
    Dec 31, 2021-$0.38-$0.58N/A+34.48%BeatN/A4N/AMar 30, 2022N/A
    Sep 30, 2021-$0.13-$0.30-$0.68 - -$0.30+56.67%Beat-103.9%4N/ANov 12, 2021$19000
    Jun 30, 2021-$0.64-$0.59-$1.15 - -$0.55-8.47%MissN/A4N/AAug 12, 2021$35000
    Mar 31, 2021-$1.90-$2.11N/A+9.95%BeatN/AN/AN/AJun 29, 2021$215000
    Dec 31, 2020-$92.90N/AN/AN/AN/AN/AN/AN/ADec 31, 2020$354000
    Sep 30, 2020$3.32N/AN/AN/AN/AN/AN/AN/ASep 30, 2020$3.25M
    Jun 30, 2020-$75.31N/AN/AN/AN/AN/AN/AN/AJun 30, 2020$511000
    Mar 31, 2020-$80.20N/AN/AN/AN/AN/AN/AN/AMar 31, 2020$705000
    Last 26 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.52, after -$1.24 the year before. It was -$2.24 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.52N/A
    Dec 31, 2024-$1.24N/A
    Dec 31, 2023-$1.92-1380.0%
    Dec 31, 2022$0.15N/A
    Dec 31, 2021-$3.05N/A
    Dec 31, 2020-$2.24N/A

    Frequently Asked Questions About BRNS

    When is Barinthus Biotherapeutics's next earnings date?

    Barinthus Biotherapeutics's next earnings report is expected for Mar 11, 2027.

    Did BRNS beat earnings estimates last quarter?

    Yes. Barinthus Biotherapeutics reported EPS of -$0.26 for the quarter ended Jun 30, 2026, above the -$0.28 estimate, a 7.14% surprise.

    What EPS do analysts expect from BRNS next quarter?

    The consensus EPS estimate for Barinthus Biotherapeutics for the quarter ended Sep 30, 2026 is -$0.26 from 2 analysts, with estimates from -$0.27 to -$0.25.

    How often does BRNS beat earnings estimates?

    Barinthus Biotherapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +13.46%.